Abstract

Summary

Daily morning blue light treatment (BLT) in PTSD patients improved objective sleep duration and increased left amygdala volume compared to amber placebo light, suggesting a neurological mechanism for light-based therapy. These findings support morning blue-enriched light as a non-pharmacologic adjunct treatment for PTSD, with implications for designing therapeutic lighting interventions in clinical and wellness settings.
Abstract

Key Findings

  • Morning blue light treatment was associated with increased left amygdala volume compared to amber placebo light in PTSD patients
  • Blue light treatment improved objective sleep duration relative to amber light control
  • Changes in amygdala volume correlated with subjective improvements in sleep quality
  • Effects were specific to blue wavelength light, as amber placebo light did not produce the same benefits
Categories

Categories

Mood & Mental Wellness: Blue light treatment improved PTSD-related outcomes including sleep and neurological changes in the amygdala.
Sleep & Circadian Health: Morning blue light exposure increased objective sleep duration in PTSD patients compared to amber placebo light.
The Science of Light: Study demonstrates spectral specificity of blue versus amber light on brain structure and sleep, relevant to therapeutic lighting protocols.
Authors

Author(s)

WDS Killgore, JR Vanuk, NS Dailey
Publication Date

Publication Year

2022
Citations

Number of Citations

3
View more publications